Global Single Roller Pump Artificial Heart Lung Machine Market Strategic Research Report

Scope of the Report

The global Single Roller Pump Artificial Heart Lung Machine market size is predicted to grow from US$ 202 million in 2025 to US$ 26.36 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.

Single Roller Pump Artificial Heart Lung Machines are widely used medical devices in extracorporeal circulation surgery, utilizing a single roller pump to drive blood flow in combination with oxygenators, heat exchangers, and other modules to achieve blood oxygenation and temperature regulation. These devices are primarily applied in cardiac surgeries, complex major vascular procedures, and heart transplants, temporarily replacing heart and lung functions during operations to ensure continuous blood flow and oxygen delivery. The single-pump design offers a simpler structure and relatively convenient operation, making it suitable for routine extracorporeal circulation procedures while providing reliable blood propulsion and cost-effectiveness. Its core advantage lies in maintaining stable blood flow and oxygenation, reducing the risks of intraoperative cardiac arrest and hypoperfusion, and enhancing surgical safety and postoperative recovery. With the growth of minimally invasive cardiac surgery and the adoption of precision perioperative management, single roller pump machines are favored for their compact structure, ease of maintenance, and user-friendly operation, becoming an essential auxiliary device in modern cardiac operations worldwide.In 2025, global Single Roller Pump Artificial Heart Lung Machines production reached approximately 827 Units and price is about 250 K USD/Unit.The average gross profit margin of this product is 45%.

The single roller pump artificial heart lung machine market is driven by the increasing global burden of cardiovascular diseases and the rising number of cardiac surgeries. Population aging and the higher prevalence of chronic heart conditions continue to increase demand for cardiac and major vascular procedures, providing a stable market foundation for extracorporeal circulation devices. The single-pump design, with its simple structure, convenient operation, and relatively lower cost, offers broad applicability in routine surgeries and medium- to small-sized hospitals. The rapid development of minimally invasive and complex surgical procedures has raised requirements for intraoperative safety and precise blood flow control, driving manufacturers to continuously improve single-pump designs and enhance device reliability and performance. Clinical studies show that high-performance single roller pump machines effectively maintain intraoperative hemodynamic stability, reduce organ ischemia risk, and improve postoperative recovery, providing long-term growth momentum for the market.

Despite technological maturity, challenges remain. Single-pump devices may have limitations in hemodynamic control during highly complex or prolonged surgeries, making them less suitable for high-risk patients. Some hospitals lack awareness of the devices’ clinical value, leading to regional disparities in deployment. Equipment cost and disposable consumables remain relatively high, constraining adoption in budget-limited institutions. Device operation requires trained medical staff, and improper use may affect surgical safety. Differences in performance, reliability, and after-sales service between brands may also influence hospital purchasing decisions and market competition.

With the expansion of cardiac surgery and the adoption of minimally invasive techniques, demand for single roller pump artificial heart lung machines shows a stable growth trend. Reliance on these devices is particularly pronounced in high-risk surgeries, heart transplants, and procedures for elderly patients. The development of enhanced recovery surgeries and digital operating rooms also raises requirements for controllability, modular design, and intelligent monitoring functions. In the future, single-pump machines are expected to integrate with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time intraoperative decision support and enabling more precise and efficient perioperative management.

The upstream industry for single roller pump artificial heart lung machines mainly includes high-precision roller pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. Roller pumps and motor modules are core components, directly impacting circulation stability and flow control accuracy. Oxygenator and heat exchanger materials require high blood compatibility, oxygenation efficiency, and temperature regulation precision, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advances in medical materials and microelectronic control technologies, upstream innovations will continue to enhance performance, safety, and intelligence, supporting product differentiation and market expansion.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Single Roller Pump Artificial Heart Lung Machine market?

What factors are driving Single Roller Pump Artificial Heart Lung Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Single Roller Pump Artificial Heart Lung Machine market opportunities vary by end market size?

How does Single Roller Pump Artificial Heart Lung Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Single Roller Pump Artificial Heart Lung Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Manual Control
• Automatic Control

Segment by Surgery Type

• Open Surgery
• Minimally Invasive
• Emergency Surgery

Segment by Application

• Cardiac Surgery
• Lung Transplant Operation
• Acute Respiratory Failure Treatment
• Others

Segment by Application

• General Hospitals
• Surgical Centers
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Single Roller Pump Artificial Heart Lung Machine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in General Hospitals, Surgical Centers, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact